US Daily Brief Today‘s Research

Research evidence excerpt

US Daily Brief Today‘s Research

Global Research

20 July 2026ab

US Daily Brief Equities

AmericasToday's Research – July 20, 2026

Joseph Parkhill

Product Manager

US Economics Weekly - Tariff news, then the FOMC (Jonathan Pingle) joseph.parkhill@ubs.com

+1-212-713 3716

Light US data next week, but tariff news and a tight legislative calendar for several

important spending bills. Peter Lennox-King

peter.lennox-king@ubs.com

Walt Disney Co (DIS, Buy, $133 from $138) - F3Q Preview: Double-digit EPS growth +1-212-713 3215

(John Hodulik)

Ryan BellExpect F26 guide to remain intact, supported by HSD growth in Experiences

& DD growth in SVOD ryan-b.bell@ubs.com

+1-212-713 1233

Live Nation Entertainment Inc (LYV, Buy, $208 from $181) - 2Q Preview: The show

goes on; Live demand intact (Batya Levi / John Hodulik)

Double digit revenue growth with improving margins; Data trackers point to positive

trends

Pfizer Inc (PFE, Neutral, $27) - *Slides* Key Phase III EZH2 Prostate Cancer Data

Coming Soon… We See 50-65% POS (Michael Yee)

We see 50-65% POS for PFE's Phase III EZH2 readout driven by very promising Phase I

randomized, controlled data

US Mid-Cap Banks - ExSqueeze Me? - Week 2 Read-thrus & Top-Picks (Timur Braziler)

The squeeze is on: positioning and M&A lifted SMIDs despite mixed 2Q fundamentals.

Credit & Decision Making Software - Earnings Offers Seasonal Opportunity for

Equifax (Kevin McVeigh)

Earnings offer seasonal opportunity as regulatory increases volatility; favor Equifax..

Initiation of Coverage - Honeywell Aerospace Inc (HONA, Neutral, $231) -

Navigating near-term nuances with upside on the horizon; Initiate at Neutral (Gavin

Parsons)

Making necessary investments to drive future opportunity

Figure 1: US INITIATIONS, ASSUMPTIONS, RATINGS & PT CHANGES